Journal of Assisted Reproduction and Genetics

, Volume 24, Issue 12, pp 629–634

Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function

Authors

    • Department of Epidemiology and Social MedicineAlbert Einstein College of Medicine
    • Department of Obstetrics and Gynecology & Women’s HealthAlbert Einstein College of Medicine
    • The Center for Human Reproduction (CHR)
    • The Foundation for Reproductive Medicine
  • Hyama Brill
    • Department of Obstetrics and GynecologyLenox Hill Hospital
    • The Center for Human Reproduction (CHR)
    • The Foundation for Reproductive Medicine
  • Norbert Gleicher
    • Department of Obstetric and GynecologyYale University School of Medicine
    • The Center for Human Reproduction (CHR)
    • The Foundation for Reproductive Medicine
Symposium of the Aging Ovary

DOI: 10.1007/s10815-007-9178-x

Cite this article as:
Barad, D., Brill, H. & Gleicher, N. J Assist Reprod Genet (2007) 24: 629. doi:10.1007/s10815-007-9178-x

Abstract

Objective

We assessed the role of DHEA supplementation on pregnancy rates in women with diminished ovarian function.

Design

This is a case control study of 190 women with diminished ovarian function. The study group includes 89 patients who used supplementation with 75 mg daily of oral, micronized DHEA for up to 4 months prior to entry into in vitro fertilization (IVF). The control group is composed of 101 couples who received infertility treatment, but did not use DHEA. The primary outcome was clinical pregnancy after the patient’s initial visit. We developed a Cox proportional hazards model to compare the proportional hazards of pregnancy among women using DHEA with the controls group.

Results

Cumulative clinical pregnancy rates were significantly higher in the study group (25 pregnancies; 28.4% vs. 11 pregnancies; 11.9%; relative hazard of pregnancy in study group (HR 3.8; 95% CI 1.2–11.8; p < 0.05).

Conclusions

DHEA treatment resulted in significantly higher cumulative pregnancy rates. These data support a beneficial effect of DHEA supplementation among women with diminished ovarian function.

Keywords

Dehydroepiandrosterone Diminished ovarian reserve Infertility In vitro fertilization, Pregnancy rates Age Life table analysis

Copyright information

© Springer Science+Business Media, LLC 2007